User:Rithish Nimmagadda: Difference between revisions

Jump to navigation Jump to search
(3 intermediate revisions by the same user not shown)
Line 34: Line 34:
#[[Retifanlimab-dlwr]]
#[[Retifanlimab-dlwr]]
#[[Velmanase alfa-tycv]]
#[[Velmanase alfa-tycv]]
#[[Elacestrant]]
#[[Pirtobrutinib]]
#[[vonoprazan, amoxicillin, and clarithromycin -(Voquezna)]]

Revision as of 18:35, 21 May 2024

<nowiki>

Your Name

Rithish Nimmagadda,MBBS

Research scholar
Contact:945-278-1660
Email: rithishnvs@gmail.com [1]

Current Position

  • research scholar (list chapters here)



Education

Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India



Pages Authored/Co-authored/Collaborated

  1. Epcoritamab-bysp
  2. Elfabrio
  3. Mirikizumab-mrkz
  4. Bimekizumab
  5. Lotilaner
  6. Quizartinib
  7. Ritlecitinib
  8. Tofersen
  9. Retifanlimab-dlwr
  10. Velmanase alfa-tycv
  11. Elacestrant
  12. Pirtobrutinib
  13. vonoprazan, amoxicillin, and clarithromycin -(Voquezna)